Medtronic MDT Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 260.7%-0.1pp | 260.8%-1.1pp | 261.9%-5.0pp | 266.9%-2.9pp | |
| Operating margin | 70.6%+3.8pp | 66.8%-1.9pp | 68.6%-5.5pp | 74.1%+6.6pp | |
| Net margin | 53.5%+1.8pp | 51.8%+3.1pp | 48.7%-7.4pp | 56%-2.4pp | |
| Returns | |||||
| Return on equity | 38.8%+4.3pp | 34.4%+4.1pp | 30.3%-3.1pp | 33.4%-2.7pp | |
| Return on invested capital | 27%+2.8pp | 24.3%+2.7pp | 21.6%-2.3pp | 23.9%-1.7pp | |
| Efficiency | |||||
| Asset turnover | 1.5×+0.1× | 1.5×+0.1× | 1.4×+0.1× | 1.3×0.0× | |
| Liquidity | |||||
| Current ratio | 9.1×+1.4× | 7.7×-1.3× | 9×+1.6× | 7.5×-2.8× | |
| Leverage | |||||
| Debt-to-equity | 2.4×0.0× | 2.3×+0.3× | 2×-0.1× | 2.1×-0.1× | |
| Net debt / EBITDA | 11.9×-1.1× | 13×+1.2× | 11.7×+0.7× | 11.1×-1.0× | |
| Per Share | |||||
| Book value per share | $151.37+0.7% | $150.29-2.2% | $153.65-1.3% | $155.67+1.0% | |
| Valuation | |||||
| Market capitalization | $467.91B+4.9% | $446.21B+2.9% | $433.66B-8.0% | $471.37B-23.6% | |
| Price / earnings | 99.5×-5.0× | 104.5×-7.4× | 111.9×+1.8× | 110.1×-25.7× | |
| Price / sales | 13.3×-0.2× | 13.5×0.0× | 13.5×-1.7× | 15.2×-4.2× | |
| Price / book | 9.6×+0.4× | 9.2×+0.7× | 8.5×-0.6× | 9.1×-2.8× | |
| EV / EBITDA | 62.8×-4.6× | 67.3×+2.5× | 64.8×-2.2× | 67×-22.3× | |
| Dividend yield | 12.5%-0.5pp | 13%-0.6pp | 13.6%+1.6pp | 12%+3.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Medtronic's profit margins?
- Medtronic (MDT) runs a 64.9% gross margin and a 17.0% operating margin, with a 13.0% net margin.
- Where do Medtronic's ratios come from?
- Every ratio is computed from Medtronic's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
